Evidence map›Paper›PMID 38857302›Full record

ReviewPigment cell & melanoma research2024

Journey through the spectacular landscape of melanocortin 1 receptor.

P R Upadhyay, V B Swope, R J Starner, L Koikov, Z A Abdel-Malek

Abstract readReview
In one paragraph

Review in Pigment cell & melanoma research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Anti-Melanogenic Potential of Malabar Spinach (Foods (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

P R UpadhyayDepartment of Dermatology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
V B SwopeDepartment of Dermatology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
R J StarnerDepartment of Dermatology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
L KoikovDepartment of Dermatology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Z A Abdel-MalekDepartment of Dermatology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Funding

REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY RESEARCHP30ES006096 · NIEHS · UNIVERSITY OF CINCINNATI · PI PINNEY, SUSAN MENGEL · 1992 to 2022
$35.4M
Targeting the Melanocortin 1 Receptor by Selective Small Analogs of α-Melanocortin for Melanoma PreventionI01BX003668 · VA · CINCINNATI VA MEDICAL CENTER RESEARCH · PI ABDEL-MALEK, ZALFA · 2018 to 2022
–
BLRD VA I01 BX003668Melanoma Know MoreNIEHS NIH HHS P30 ES006096NIEHS p30 ES006096University of Cincinnati Cancer CenterU.S. Department of Veterans Affairs
6 · The paper itself

Abstract

The physiological role of α-melanocyte stimulating hormone in regulating integumental pigmentation of many vertebrate species has been recognized since the 1960's. However, its physiological significance for human pigmentation remained enigmatic until the 1990's. α-Melanocyte stimulating hormone and related melanocortins are synthesized locally in the skin, primarily by keratinocytes, in addition to the pituitary gland, and therefore act as paracrine factors for melanocytes. Human melanocytes express the melanocortin 1 receptor, which recognizes α-melanocyte stimulating hormone and the related adrenocorticotropic hormone as agonists. This review summarizes the current knowledge of the pleotropic effects of the activated melanocortin 1 receptor that maintain human melanocyte homeostasis by regulating melanogenesis and the response to environmental stressors, mainly solar radiation. Certain allelic variants of the melanocortin 1 receptor gene are associated with specific pigmentary phenotypes in various human populations. Variants associated with red hair phenotype compromise the function of the encoded receptor. Activation of the human melanocortin 1 receptor regulates eumelanin synthesis and enhances DNA damage response of melanocytes to solar radiation and oxidative stressors. We describe how synthetic selective melanocortin 1 receptor agonists can be efficacious as sunless tanning agents, for treatment of vitiligo and photosensitivity disorders, and for prevention of skin cancer, including melanoma.

Indexed as

MelanocytesReceptor, Melanocortin, Type 1alpha-MSHAnimalsHumansMelaninsSkin Pigmentationalpha-MSHMelaninsReceptor, Melanocortin, Type 1DNA repaireumelanin synthesishuman MC1Roxidative stressphotoprotectionα‐melanocyte stimulating hormone

Identifiers

PMID38857302
PMCPMC11479856

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.